XML 20 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
3 Months Ended
Nov. 30, 2013
Share-Based Compensation [Abstract]  
Share-Based Compensation

Note 11 – Share-Based Compensation

The Company’s current share-based compensation plans, approved by the stockholders of the Company, provides for awards of stock options, restricted shares, restricted stock units (“RSUs”), stock appreciation rights, performance shares and performance stock units (“PSUs”) to employees and non-employee directors of the Company.  The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors based on estimated fair values. Share-based compensation expense was $1.2 million for each of the three months ended November 30, 2013 and 2012.

 

The following table illustrates the type and fair value of the share-based compensation awards granted during the three month periods ended November 30, 2013 and 2012, respectively:

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended November 30,

 

2013

 

2012

 

 

 

Grant-Date
Fair Value

 

 

 

Grant-Date
Fair Value

 

# Granted

 

Per Award

 

# Granted

 

Per Award

Stock options

25,394 

 

$

40.42 

 

 

24,684 

 

$

40.09 

 

RSUs

29,619 

 

$

74.84 

 

 

25,279 

 

$

74.31 

 

PSUs

13,434 

 

$

74.84 

 

 

13,072 

 

$

74.31 

 

 

The RSUs granted in 2013 and 2012 consisted of 2,977 and 2,057, respectively, of awards that will be settled in cash. The weighted average stock price on the date of grant was $76.39 and $75.68 for 2013 and 2012, respectively.

 

The following table provides the assumptions used in determining the fair value of the option awards for the three month periods ended November 30, 2013 and 2012, respectively:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Grant Year

 

 

 

 

 

 

 

2013

 

 

2012

Weighted-average dividend yield

 

 

 

 

 

 

0.68% 

 

 

0.61% 

Weighted-average volatility

 

 

 

 

 

 

55.23% 

 

 

56.26% 

Range of risk-free interest rates

 

 

 

 

 

 

1.91% 

 

 

1.21% 

Weighted-average expected lives

 

 

 

 

 

 

7 years

 

 

7 years